当前位置: 首页 > 期刊 > 《中外医学研究》 > 2013年第6期
编号:13170918
内皮源性心血管活性物质与心血管疾病分析(3)
http://www.100md.com 2013年2月25日 《中外医学研究》 2013年第6期
     [9]Katwa L C,Ratajska A,Cleutjens J P M,et al.Angiotensin converting enzyme and kininase-Ⅱ-like activities in cultured valvular interstitial cells of the rat heart[J].Cardiovascular Research,1995,45(2):412-413.

    [10]Haber H,Powers E,Gimple L,et al.Intracoronary angiotensinconverting emyme inhibition improves diastolic function in patients with hypertensive left ventricular hyPertrophy[J].Circulation,1994,11(9):385-386.

    [11]Omland T,Lie R T,Aakvaag A,et al.Plasma endothelin determination as aprognostic indicator of 1-year mortality after acutemyocardial infarction[J].Circulation,1994,65(15):943-944.

    [12]Parratt J R.Cardioprotection by AngⅠotensin converting enzymeinhibitors-the experlmental evidence[J].Cardiovascular Research,1994,8(1):102-103.

    [13]Mebazaa A,Wetzel R,Cherian M,et al.Comparison between endocardial and great vessel endotheIiaI cells:Morphology, growth and prostaglandin release[J].American Journal of Physiology,1995,9(12):687-688.

    [14]Dinerman J L,Lowenstein C J,Snyder S H.Molecular mechanism of nitric oxide regulation[J].Circ Res,1993,73(2):217-218.

    [15]Paulus W J,Vantrimpont P J,Shah A M.Acute effects of nitricoxide on left ventricular relaxation and diastolic distensibility inman[J].Circulation,1994,19(6):400-401.

    [16]Ferro C J.The clinical potenti, 百拇医药(王智明)
上一页1 2 3